BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 17192577)

  • 1. Adrenocortical tumorigenesis.
    Beuschlein F; Reincke M
    Ann N Y Acad Sci; 2006 Nov; 1088():319-34. PubMed ID: 17192577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenal incidentalomas: presentation and clinical work-up.
    Beuschlein F
    Horm Res; 2007; 68 Suppl 5():191-4. PubMed ID: 18174744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenocortical tumorigenesis in transgenic mice: the role of luteinizing hormone receptor and transcription factors GATA-4 and GATA-61.
    Rahman NA; Kiiveri S; Siltanen S; Levallet J; Kero J; Lensu T; Wilson DB; Heikinheimo MT; Huhtaniemi IT
    Reprod Biol; 2001 Jul; 1(1):5-9. PubMed ID: 14666170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the inhibin/activin system and luteinizing hormone in adrenocortical tumorigenesis.
    Beuschlein F; Looyenga BD; Reincke M; Hammer GD
    Horm Metab Res; 2004 Jun; 36(6):392-6. PubMed ID: 15241730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathophysiology, diagnosis and prognosis of adrenocortical tumors revisited by transcriptome analyses.
    Assié G; Guillaud-Bataille M; Ragazzon B; Bertagna X; Bertherat J; Clauser E
    Trends Endocrinol Metab; 2010 May; 21(5):325-34. PubMed ID: 20097573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenocorticotropic hormone-independent Cushing's syndrome.
    Bourdeau I; Lampron A; Costa MH; Tadjine M; Lacroix A
    Curr Opin Endocrinol Diabetes Obes; 2007 Jun; 14(3):219-25. PubMed ID: 17940443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular markers and the pathogenesis of adrenocortical cancer.
    Soon PS; McDonald KL; Robinson BG; Sidhu SB
    Oncologist; 2008 May; 13(5):548-61. PubMed ID: 18515740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenal cortical tumors and multiple endocrine neoplasia-related syndromes.
    Haase M; Willenberg HS
    Minerva Endocrinol; 2009 Jun; 34(2):123-35. PubMed ID: 19471237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease.
    de Cremoux P; Rosenberg D; Goussard J; Brémont-Weil C; Tissier F; Tran-Perennou C; Groussin L; Bertagna X; Bertherat J; Raffin-Sanson ML
    Endocr Relat Cancer; 2008 Jun; 15(2):465-74. PubMed ID: 18508999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the role of genetic alterations in adrenocortical tumorigenesis.
    Herbet M; Feige JJ; Thomas M
    Mol Cell Endocrinol; 2009 Mar; 300(1-2):169-74. PubMed ID: 19007854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Telomerase expression in various lesions of adrenal cortex].
    Mao QZ; Rong S; Fan JH; Ji ZG; Li HZ; Zang MF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):188-9. PubMed ID: 12905801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in adrenocortical tumors.
    Reincke M
    Horm Metab Res; 1998; 30(6-7):447-55. PubMed ID: 9694578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant GPCR expression is a sufficient genetic event to trigger adrenocortical tumorigenesis.
    Mazzuco TL; Chabre O; Feige JJ; Thomas M
    Mol Cell Endocrinol; 2007 Feb; 265-266():23-8. PubMed ID: 17250952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenocortical tumorigenesis, luteinizing hormone receptor and transcription factors GATA-4 and GATA-6.
    Vuorenoja S; Rivero-Muller A; Kiiveri S; Bielinska M; Heikinheimo M; Wilson DB; Huhtaniemi IT; Rahman NA
    Mol Cell Endocrinol; 2007 Apr; 269(1-2):38-45. PubMed ID: 17337116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenocortical carcinomas: a 12-year clinicopathologic study of 15 cases.
    Menon V; Krishnamurthy SV
    Indian J Pathol Microbiol; 2006 Jan; 49(1):7-11. PubMed ID: 16625963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructural and biochemical studies in human adrenocortical adenomas associated with primary aldosteronism.
    Murakoshi M; Osamura Y; Watanabe K; Nomoto Y; Sakai H
    Tokai J Exp Clin Med; 1983 Nov; 8(4):375-83. PubMed ID: 6679942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenocortical cancer: pathophysiology and clinical management.
    Libè R; Fratticci A; Bertherat J
    Endocr Relat Cancer; 2007 Mar; 14(1):13-28. PubMed ID: 17395972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse strain susceptibility to gonadectomy-induced adrenocortical tumor formation correlates with the expression of GATA-4 and luteinizing hormone receptor.
    Bielinska M; Parviainen H; Porter-Tinge SB; Kiiveri S; Genova E; Rahman N; Huhtaniemi IT; Muglia LJ; Heikinheimo M; Wilson DB
    Endocrinology; 2003 Sep; 144(9):4123-33. PubMed ID: 12933687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary aldosteronism and adrenal incidentaloma.
    Pop C; Fanea A; Ribier A; Gueyffier F; Gouton M
    Rom J Intern Med; 1998; 36(1-2):117-20. PubMed ID: 10660977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sporadic adrenocortical tumors: genetics and perspectives for the pathologist].
    Tissier F
    Ann Pathol; 2008 Oct; 28(5):409-16. PubMed ID: 19068395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.